Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results Up to 3 Years from the RELIEVE-AD Study.

Alexa B. Kimball,Dimittri Delevry,Min Yang,Chien-Chia Chuang,Zhixiao Wang,Gaëlle Bégo-Le-Bagousse,Bruno Martins,Eric Wu,Brad Shumel,Jessie Wang,Debra Sierka,Jingdong Chao,Bruce Strober

Dermatology and therapy（2023）

引用 1|浏览24

暂无评分

关键词

Atopic dermatitis,Disease control,Dupilumab,Health-related quality of life,Long-term treatment response,Patient-reported outcomes,Real-world study,Treatment satisfaction,Work productivity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要